Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
PHASE2
This phase II trial compares cabozantinib alone and the combination of cabo...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2
This phase II LUNG-MAP treatment trial studies how well sapanisertib and do...
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)
PHASE2
Primary Objectives:
Doublet Cohort
Part 1 (safety run-in):
To assess the...